(Q38237495)

English

Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway

scientific article published on September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway (English)

1 reference

Europe PubMed Central

31 August 2017

0 references

ventricular dysfunction

1 reference

based on heuristic

inferred from title

left ventricular dysfunction

1 reference

based on heuristic

inferred from title

author name string

John D Groarke

1

1 reference

Europe PubMed Central

31 August 2017

Toni K Choueiri

2

1 reference

Europe PubMed Central

31 August 2017

David Slosky

3

1 reference

Europe PubMed Central

31 August 2017

Susan Cheng

4

1 reference

Europe PubMed Central

31 August 2017

Javid Moslehi

5

1 reference

Europe PubMed Central

31 August 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

31 August 2017

Current treatment options in cardiovascular medicine

1 reference

Europe PubMed Central

31 August 2017

16

1 reference

Europe PubMed Central

31 August 2017

9

1 reference

Europe PubMed Central

31 August 2017

335

1 reference

Europe PubMed Central

31 August 2017

https://scigraph.springernature.com/pub.10.1007/s11936-014-0335-0

0 references

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Sunitinib, hypertension, and heart failure: a model for kinase inhibitor-mediated cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cancer-drug discovery and cardiovascular surveillance.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiac magnetic resonance imaging in sunitinib malate-related cardiomyopathy: no late gadolinium enhancement.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Conditional HIF-1alpha expression produces a reversible cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Carvedilol: just another Beta-blocker or a powerful cardioprotector?

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Management of hypertension in angiogenesis inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Hypertension associated with angiogoenesis inhibitors: what do oncologists really do in daily routine? A small survey

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

An algorithm for the management of hypertension in the setting of vascular endothelial growth factor signaling inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0335-0

21 January 2018

Managing cardiotoxicity of chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversible cardiomyopathy associated with sunitinib and sorafenib

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered left ventricular diastolic performance in oncologic patients treated with epirubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Soci

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formation of plexiform lesions in experimental severe pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/25099086

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11936-014-0335-0

1 reference

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38237495&oldid=2102212620"